Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,957.50    33.00 (1.71%)
Bid:
1,961.00
Ask:
1,961.50
Spread: 0.50 (0.025%)
Market Cap: £78.45b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Block Listing Application

20 Dec 2024 09:00

RNS Number : 8037Q
GSK PLC
20 December 2024
 

 

GSK plc

 

Block listing Application

 

 

Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 700,000 Ordinary Shares of 31¼p each ('Shares') to be admitted to the Official List.

 

The Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2012.

 

When issued, the Shares will rank pari passu with the existing Ordinary Shares of 31¼p each.

 

Admission is expected to be effective on 23 December 2024.

 

 

 

 

V A Whyte

Company Secretary

 

20 December 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSQKCBKNBDDNBD
Date   Source Headline
19th Nov 20257:15 amRNSTransfer of Treasury Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20253:30 pmRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20253:30 pmRNSBlock listing Interim Review
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20253:00 pmRNSGSK publishes provisional dividend dates
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20253:00 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:05 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNS3rd Quarter Results
28th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSGSK ADC gets orphan drug designation in the EU
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSBlenrep approved by US FDA in multiple myeloma
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:05 amRNSPositive data for low carbon version Ventolin MDI
22nd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSLatozinemab data read out
21st Oct 20257:05 amRNSPositive CHMP Opinion for GSK on Shingrix PFS
21st Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSGSK share positive Ph3 data on tebipenem HBr
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20253:30 pmRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20253:30 pmRNSDirector/PDMR Shareholding
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSGSK receives expanded Shingrix approval in China
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20253:30 pmRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20253:30 pmRNSDirector/PDMR Shareholding
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.